Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Private medical university in Tbilisi offering MD programs to Georgian and international students, accredited for international medical education.
Group parent — controls 2 companies · ownership
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 18,874 | 17,286 | 15,874 | 17,252 | 16,988 | 18,411 | 18,257 | -0.6% | |
| Total COGS | 6,132 | 1,150 | 868 | 958 | 3,382 | 5,077 | 5,358 | -2.2% |
| Gross Profit | 12,742 | 16,136 | 15,006 | 16,294 | 13,606 | 13,333 | 12,899 | +0.2% |
| Gross Margin | 67.5% | 93.3% | 94.5% | 94.4% | 80.1% | 72.4% | 70.7% | |
| Other Operating Income | 0 | 220 | 538 | 0 | 94 | 123 | 133 | -9.7% |
| 8,146 | 12,063 | 11,392 | 11,826 | 11,182 | 13,296 | 13,951 | +9.4% | |
| EBITDA | 4,596 | 4,294 | 4,152 | 4,468 | 2,518 | 160 | 919 | nmf |
| EBITDA Margin | 24.4% | 24.8% | 26.2% | 25.9% | 14.8% | 0.9% | 5.0% | |
| Total D&A | 530 | 645 | 515 | 629 | 623 | 1,050 | 1,040 | +11.9% |
| EBIT / Operating Income | 4,066 | 3,648 | 3,637 | 3,839 | 1,895 | 890 | 1,960 | nmf |
| Total Interest Expense | 0 | 988 | 905 | 970 | 2,662 | 2,096 | 237 | -24.8% |
| 0 | 623 | 448 | 0 | 502 | 680 | 17 | -51.4% | |
| Profit Before Tax | 4,066 | 2,038 | 2,284 | 2,870 | 1,269 | 3,666 | 2,214 | nmf |
| Total Income Tax | 0 | 194 | 305 | 0 | 0 | 106 | 0 | -14.1% |
| Net Profit / (Loss) | 4,692 | 1,794 | 1,908 | 2,823 | 1,308 | 3,772 | 2,214 | nmf |
| Net Margin | 24.9% | 10.4% | 12.0% | 16.4% | 7.7% | 20.5% | 12.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →